These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 20727773

  • 1. Identification of novel antitubercular compounds through hybrid virtual screening approach.
    Muddassar M, Jang JW, Hong SK, Cho YS, Kim EE, Keum KC, Oh T, Cho SN, Pae AN.
    Bioorg Med Chem; 2010 Sep 15; 18(18):6914-21. PubMed ID: 20727773
    [Abstract] [Full Text] [Related]

  • 2. Structure-based design of a novel class of potent inhibitors of InhA, the enoyl acyl carrier protein reductase from Mycobacterium tuberculosis: a computer modelling approach.
    Subba Rao G, Vijayakrishnan R, Kumar M.
    Chem Biol Drug Des; 2008 Nov 15; 72(5):444-9. PubMed ID: 19012578
    [Abstract] [Full Text] [Related]

  • 3. Knowledge based identification of potent antitubercular compounds using structure based virtual screening and structure interaction fingerprints.
    Kumar A, Chaturvedi V, Bhatnagar S, Sinha S, Siddiqi MI.
    J Chem Inf Model; 2009 Jan 15; 49(1):35-42. PubMed ID: 19063713
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cross-docking study on InhA inhibitors: a combination of Autodock Vina and PM6-DH2 simulations to retrieve bio-active conformations.
    Stigliani JL, Bernardes-Génisson V, Bernadou J, Pratviel G.
    Org Biomol Chem; 2012 Aug 21; 10(31):6341-9. PubMed ID: 22751934
    [Abstract] [Full Text] [Related]

  • 6. Crystallographic and pre-steady-state kinetics studies on binding of NADH to wild-type and isoniazid-resistant enoyl-ACP(CoA) reductase enzymes from Mycobacterium tuberculosis.
    Oliveira JS, Pereira JH, Canduri F, Rodrigues NC, de Souza ON, de Azevedo WF, Basso LA, Santos DS.
    J Mol Biol; 2006 Jun 09; 359(3):646-66. PubMed ID: 16647717
    [Abstract] [Full Text] [Related]

  • 7. Global Bayesian models for the prioritization of antitubercular agents.
    Prathipati P, Ma NL, Keller TH.
    J Chem Inf Model; 2008 Dec 09; 48(12):2362-70. PubMed ID: 19053518
    [Abstract] [Full Text] [Related]

  • 8. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
    Lokesh BVS, Prasad YR, Shaik AB.
    Infect Disord Drug Targets; 2019 Dec 09; 19(3):310-321. PubMed ID: 30556506
    [Abstract] [Full Text] [Related]

  • 9. Design, synthesis and docking studies of quinoline-oxazolidinone hybrid molecules and their antitubercular properties.
    Thomas KD, Adhikari AV, Chowdhury IH, Sandeep T, Mahmood R, Bhattacharya B, Sumesh E.
    Eur J Med Chem; 2011 Oct 09; 46(10):4834-45. PubMed ID: 21880400
    [Abstract] [Full Text] [Related]

  • 10. Discovery of potential new InhA direct inhibitors based on pharmacophore and 3D-QSAR analysis followed by in silico screening.
    Lu XY, Chen YD, Jiang YJ, You QD.
    Eur J Med Chem; 2009 Sep 09; 44(9):3718-30. PubMed ID: 19428156
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Synthesis, antitubercular activity and docking study of novel cyclic azole substituted diphenyl ether derivatives.
    Kini SG, Bhat AR, Bryant B, Williamson JS, Dayan FE.
    Eur J Med Chem; 2009 Feb 09; 44(2):492-500. PubMed ID: 18538450
    [Abstract] [Full Text] [Related]

  • 14. Development of gallic acid formazans as novel enoyl acyl carrier protein reductase inhibitors for the treatment of tuberculosis.
    Saharan VD, Mahajan SS.
    Bioorg Med Chem Lett; 2017 Feb 15; 27(4):808-815. PubMed ID: 28117201
    [Abstract] [Full Text] [Related]

  • 15. Ligand based virtual screening and biological evaluation of inhibitors of chorismate mutase (Rv1885c) from Mycobacterium tuberculosis H37Rv.
    Agrawal H, Kumar A, Bal NC, Siddiqi MI, Arora A.
    Bioorg Med Chem Lett; 2007 Jun 01; 17(11):3053-8. PubMed ID: 17418569
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Docking studies on novel alkaloid tryptanthrin and its analogues against enoyl-acyl carrier protein reductase (InhA) of Mycobacterium tuberculosis.
    Tripathi A, Wadia N, Bindal D, Jana T.
    Indian J Biochem Biophys; 2012 Dec 01; 49(6):435-41. PubMed ID: 23350278
    [Abstract] [Full Text] [Related]

  • 18. Identification of novel potential antibiotics for tuberculosis by in silico structure-based drug screening.
    Izumizono Y, Arevalo S, Koseki Y, Kuroki M, Aoki S.
    Eur J Med Chem; 2011 May 01; 46(5):1849-56. PubMed ID: 21397998
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.